344 related articles for article (PubMed ID: 16454713)
1. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G; Barbarini G
Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
Feleke Y; Fekade D; Mezegebu Y
Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
Bradbury RA; Samaras K
Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of metabolic complications after 10 years of antiretroviral treatment in Senegal].
Diouf A; Cournil A;
Bull Soc Pathol Exot; 2014 Oct; 107(4):234-7. PubMed ID: 24683016
[TBL] [Abstract][Full Text] [Related]
7. [Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].
Streinu-Cercel A; Ion DA; Chivu LI; Chivu RD
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):521-5. PubMed ID: 17571539
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.
Cahn P; Leite O; Rosales A; Cabello R; Alvarez CA; Seas C; Carcamo C; Cure-Bolt N; L'Italien GP; Mantilla P; Deibis L; Zala C; Suffert T
Braz J Infect Dis; 2010; 14(2):158-66. PubMed ID: 20563442
[TBL] [Abstract][Full Text] [Related]
9. Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.
Fantoni M; Del Borgo C; Autore C; Barbaro G
Ital Heart J; 2002 May; 3(5):294-9. PubMed ID: 12066561
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
Barbaro G
Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
[TBL] [Abstract][Full Text] [Related]
11. HIV and increased risk of cardiovascular diseases.
Das S
Sex Health; 2005; 2(4):219-21. PubMed ID: 16402668
[TBL] [Abstract][Full Text] [Related]
12. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
[TBL] [Abstract][Full Text] [Related]
13. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy.
Resino S; Micheloud D; Lorente R; Bellon JM; Navarro ML; Munoz-Fernandez MA
HIV Med; 2011 Jan; 12(1):54-60. PubMed ID: 20497248
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic changes in HIV infected patient].
Castelo Filho A; Abrão P
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):5-7. PubMed ID: 17435849
[No Abstract] [Full Text] [Related]
16. Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter.
Barbaro G
Pharmacology; 2003 Dec; 69(4):177-9. PubMed ID: 14624056
[TBL] [Abstract][Full Text] [Related]
17. Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.
Tomazic J; Silic A; Karner P; Vidmar L; Maticic M; Poljak M; Ihan A; Janez A
Wien Klin Wochenschr; 2004 Nov; 116(21-22):755-9. PubMed ID: 15628647
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
ter Hofstede HJ; Burger DM; Koopmans PP
Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
[No Abstract] [Full Text] [Related]
19. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
Leclercq P; Blanc M
Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G; Klatt EC
Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
